Filed 1mo ago· Apr 14, 2026
26 days to disclose
John Boozman
RSenateArkansas
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.3% vs S&P 500
Trade dateMar 19, 2026
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.




































































































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Apr 14, 2026 1mo ago | ![]() John Boozman RSenateArkansas | ↓sold | Johnson & Johnson JNJ | Mar 19, 2026 26 days to disclose | Flat·+0.0% +1.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 13, 2026 1mo ago | ![]() Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Mar 26, 2026 18 days to disclose | Flat·+0.0% +1.9% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | ![]() Richard McCormick RHouseGeorgia-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Investigations and Oversight | Mar 19, 2026 19 days to disclose | Flat·+0.0% +1.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2026 1mo ago | ![]() Richard McCormick RHouseGeorgia-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Investigations and Oversight | Mar 19, 2026 19 days to disclose | Flat·+0.0% +1.3% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 6, 2026 1mo ago | ![]() Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 10, 2026 27 days to disclose | Bad buy·−$407-5.1% −2.1% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 19, 2026 3mo ago | ![]() Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Jan 23, 2026 27 days to disclose | Flat·+0.0% −5.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 15, 2026 4mo ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Dec 18, 2025 28 days to disclose | Flat·+0.0% −3.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 2, 2026 5mo ago | ![]() Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 9, 2025 24 days to disclose | Good buy·+$1.3K+15.7% +16.6% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 19, 2025 5mo ago | ![]() Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Nov 20, 2025 29 days to disclose | Flat·+0.0% −1.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Dec 11, 2025 5mo ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Nov 13, 2025 28 days to disclose | Flat·+0.0% −2.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 9, 2025 5mo ago | ![]() Richard McCormick RHouseGeorgia-07 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Investigations and Oversight | Nov 5, 2025 34 days to disclose | Good buy·+$1.9K+24.4% +22.4% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 22, 2025 6mo ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Johnson & Johnson JNJ | Oct 10, 2025 43 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 22, 2025 6mo ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Johnson & Johnson JNJ | Oct 10, 2025 43 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 31, 2025 21 days to disclose | Flat·+0.0% +3.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Good buy·+$1.8K+22.4% +19.4% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 21, 2025 6mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Oct 30, 2025 22 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Johnson & Johnson JNJ | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 5, 2025 8mo ago | ![]() Sheri Biggs RHouseSouth Carolina-03 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Research and Technology | Mar 19, 2025 200 days to disclose · 155 past 45-day window | Flat·+0.0% +1.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 17, 2025 8mo ago | ![]() Richard McCormick RHouseGeorgia-07 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Investigations and Oversight | Mar 15, 2023 917 days to disclose · 872 past 45-day window | Good buy·+$4K+49.9% +32.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Aug 4, 2025 39 days to disclose | Good buy·+$2.8K+35.2% +23.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Johnson & Johnson JNJ | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3.8K+47.6% +47.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | ![]() Kelly Morrison DHouseMinnesota-03 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health | Aug 19, 2025 23 days to disclose | Flat·+0.0% +8.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 11, 2025 8mo ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Aug 14, 2025 28 days to disclose | Flat·+0.0% +10.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2025 9mo ago | ![]() Thomas H. Kean Jr. RHouseNew Jersey-07 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Jul 31, 2025 20 days to disclose | Flat·+0.0% +13.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 20, 2025 9mo ago | ![]() Ritchie Torres DHouseNew York-15 | ↑bought | Johnson & Johnson JNJ | Sep 26, 2024 328 days to disclose · 283 past 45-day window | Good buy·+$3.3K+41.0% +16.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 24, 2025 50 days to disclose · 5 past 45-day window | Flat·+0.0% +11.0% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 13, 2025 9mo ago | ![]() Lisa C. McClain RHouseMichigan-09 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 17, 2025 57 days to disclose · 12 past 45-day window | Good buy·+$4.1K+51.8% +40.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 14, 2025 10mo ago | ![]() Scott Franklin RHouseFlorida-18 | ↓sold | Johnson & Johnson JNJ | Jun 16, 2025 28 days to disclose | Flat·+0.0% +9.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jul 7, 2025 11mo ago | ![]() Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 10, 2025 27 days to disclose | Good buy·+$3.8K+47.8% +38.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2025 11mo ago | ![]() Scott Franklin RHouseFlorida-18 | ↑bought | Johnson & Johnson JNJ | Aug 7, 2024 330 days to disclose · 285 past 45-day window | Good buy·+$3.6K+45.6% +43.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 22, 2025 11mo ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↓sold | Johnson & Johnson JNJ | May 12, 2025 41 days to disclose | Flat·+0.0% +9.2% vs S&P 500 | $50K-$100K midpoint $75K |
Jun 21, 2025 11mo ago | ![]() Pete Sessions RHouseTexas-17 | ↓sold | Johnson & Johnson JNJ | Jun 12, 2025 9 days to disclose | Flat·+0.0% +8.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jun 6, 2025 12mo ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Johnson & Johnson JNJ | May 30, 2025 7 days to disclose | Good buy·+$15.9K+49.0% +37.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 14, 2025 1.1y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Johnson & Johnson JNJ | Apr 9, 2025 35 days to disclose | Flat·+0.0% +7.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | ![]() Julie Johnson DHouseTexas-32 | ↓sold | Johnson & Johnson JNJ | Apr 1, 2025 43 days to disclose | Flat·+0.0% +3.6% vs S&P 500 | $1K-$15K midpoint $8K |
May 12, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↓sold | Johnson & Johnson JNJ | Apr 21, 2025 21 days to disclose | Flat·+0.0% +12.0% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | May 5, 2025 1 day to disclose | Good buy·+$3.9K+49.2% +41.7% vs S&P 500 | $1K-$15K midpoint $8K |
May 6, 2025 1.1y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Johnson & Johnson JNJ | Apr 29, 2025 7 days to disclose | Flat·+0.0% +6.6% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 28, 2025 1.1y ago | ![]() Robert P. Bresnahan Jr. RHousePennsylvania-08 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Conservation, Research, and Biotechnology | Apr 8, 2025 20 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 23, 2025 1.1y ago | ![]() George Whitesides DHouseCalifornia-27 | ↓sold | Johnson & Johnson JNJ | Mar 24, 2025 30 days to disclose | Flat·+0.0% +2.2% vs S&P 500 | $100K-$250K midpoint $175K |
Apr 16, 2025 1.1y ago | ![]() Bruce Westerman RHouseArkansas-04 | ↑bought | Johnson & Johnson JNJ | Mar 3, 2025 44 days to disclose | Good buy·+$3.1K+38.3% +39.0% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 11, 2025 1.1y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Johnson & Johnson JNJ | Mar 5, 2025 37 days to disclose | Good buy·+$13K+40.1% +40.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 10, 2025 1.1y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Johnson & Johnson JNJ | Mar 7, 2025 34 days to disclose | Flat·+0.0% −0.5% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 7, 2025 1.2y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↑bought | Johnson & Johnson JNJ | Mar 31, 2025 7 days to disclose | Good buy·+$12.8K+39.5% +37.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Apr 7, 2025 1.2y ago | ![]() Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 4, 2025 34 days to disclose | Good buy·+$3.2K+39.8% +39.6% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 9, 2025 1.2y ago | ![]() Jefferson Shreve RHouseIndiana-06 | ↑bought | Johnson & Johnson JNJ | Feb 24, 2025 13 days to disclose | Good buy·+$13.4K+41.3% +40.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 11, 2025 1.3y ago | ![]() Gilbert Ray Cisneros Jr. DHouseCalifornia-31 | ↓sold | Johnson & Johnson JNJ | Jan 24, 2025 18 days to disclose | Flat·+0.0% +2.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Jan 24, 2025 17 days to disclose | Good buy·+$4.6K+57.5% +54.6% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Jan 21, 2025 20 days to disclose | Good buy·+$4.5K+56.1% +51.9% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 10, 2025 1.3y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Jan 16, 2025 25 days to disclose | Good buy·+$4.5K+56.5% +51.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 27, 2025 1.3y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Jan 8, 2025 19 days to disclose | Good buy·+$5K+62.6% +56.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 27, 2025 1.3y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Jan 8, 2025 19 days to disclose | Good buy·+$5K+62.6% +56.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 27, 2025 1.3y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Jan 8, 2025 19 days to disclose | Good buy·+$5K+62.6% +56.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 15, 2025 1.4y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 31, 2024 15 days to disclose | Flat·+0.0% +8.0% vs S&P 500 | $100K-$250K midpoint $175K |
Jan 14, 2025 1.4y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Dec 12, 2024 33 days to disclose | Good buy·+$4.7K+58.2% +52.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 8, 2025 1.4y ago | ![]() Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 10, 2024 29 days to disclose | Good buy·+$4.4K+55.0% +51.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 6, 2025 1.4y ago | ![]() Virginia Foxx RHouseNorth Carolina-05 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Dec 6, 2024 31 days to disclose | Good buy·+$4.4K+54.9% +52.0% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 27, 2024 1.4y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Dec 24, 2024 3 days to disclose | Good buy·+$4.7K+58.6% +52.0% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 9, 2024 1.5y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Johnson & Johnson JNJ | Nov 8, 2024 31 days to disclose | Good buy·+$3.9K+48.8% +49.9% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2024 1.5y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Nov 26, 2024 9 days to disclose | Good buy·+$3.9K+48.8% +47.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 5, 2024 1.5y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↑bought | Johnson & Johnson JNJ | Nov 22, 2024 13 days to disclose | Good buy·+$3.9K+49.1% +46.1% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 27, 2024 1.5y ago | ![]() Marjorie Taylor Greene RHouseGeorgia-14 | ↑bought | Johnson & Johnson JNJ | Nov 25, 2024 2 days to disclose | Good buy·+$3.9K+48.5% +46.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 15, 2024 1.5y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 29, 2024 17 days to disclose | Flat·+0.0% | $15K-$50K midpoint $32.5K |
Oct 10, 2024 1.6y ago | ![]() Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 10, 2024 30 days to disclose | Good buy·+$3.1K+38.2% +42.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 6, 2024 1.7y ago | ![]() John James RHouseMichigan-10 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Sep 4, 2024 2 days to disclose | Flat·+0.0% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | ![]() John James RHouseMichigan-10 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Good buy·+$4.6K+57.1% +39.5% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 21, 2024 1.8y ago | ![]() Sheldon Whitehouse DSenateRhode Island | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Jul 3, 2024 49 days to disclose · 4 past 45-day window | Flat·+0.0% +3.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 21, 2024 1.8y ago | ![]() Sheldon Whitehouse DSenateRhode Island | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Jul 3, 2024 49 days to disclose · 4 past 45-day window | Flat·+0.0% +3.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 21, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↓sold | Johnson & Johnson JNJ | Feb 1, 2024 202 days to disclose · 157 past 45-day window | Flat·+0.0% +4.4% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 20, 2024 1.8y ago | ![]() Scott Franklin RHouseFlorida-18 | ↑bought | Johnson & Johnson JNJ | Aug 7, 2024 13 days to disclose | Good buy·+$14.8K+45.6% +43.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 20, 2024 1.8y ago | ![]() Scott Franklin RHouseFlorida-18 | ↑bought | Johnson & Johnson JNJ | Aug 2, 2024 18 days to disclose | Good buy·+$3.6K+45.5% +47.1% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Jul 2, 2024 45 days to disclose | Good buy·+$4.7K+58.4% +55.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 16, 2024 1.8y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↑bought | Johnson & Johnson JNJ | Jul 2, 2024 45 days to disclose | Good buy·+$4.7K+58.4% +55.6% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 8, 2024 1.8y ago | ![]() Rick W. Allen RHouseGeorgia-12 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jul 16, 2024 23 days to disclose | Missed gain·−$16.5K-50.7% −24.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 6, 2024 1.8y ago | ![]() Jared Moskowitz DHouseFlorida-23 | ↑bought | Johnson & Johnson JNJ | Jul 1, 2024 36 days to disclose | Good buy·+$4.6K+58.0% +55.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 15, 2024 1.9y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 4, 2024 41 days to disclose | Good buy·+$4.3K+53.9% +18.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 10, 2024 1.9y ago | ![]() Rick W. Allen RHouseGeorgia-12 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Employment, Labor, and Pensions | Jun 13, 2024 27 days to disclose | Missed gain·−$18.3K-56.4% −24.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jul 9, 2024 1.9y ago | ![]() Josh Gottheimer DHouseNew Jersey-05 | ↓sold | Johnson & Johnson JNJ | Jun 21, 2024 18 days to disclose | Flat·+0.0% +1.2% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 3, 2024 1.9y ago | ![]() Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jun 4, 2024 29 days to disclose | Good buy·+$4.3K+53.9% +18.8% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 12, 2024 2.1y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 5, 2024 38 days to disclose | Good buy·+$3.4K+42.2% +1.4% vs S&P 500 | $1K-$15K midpoint $8K |
Apr 9, 2024 2.2y ago | ![]() Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Mar 5, 2024 35 days to disclose | Good buy·+$3.4K+42.2% +1.4% vs S&P 500 | $1K-$15K midpoint $8K |
Feb 6, 2024 2.3y ago | ![]() Kathy Manning DHouseNorth Carolina-06 | ↓sold | Johnson & Johnson JNJ | Jan 23, 2024 14 days to disclose | Flat·+0.0% +6.1% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 24, 2024 2.4y ago | ![]() Blake D. Moore RHouseUtah-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jan 19, 2024 5 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $15K-$30K midpoint $22.5K |
Jan 24, 2024 2.4y ago | ![]() Blake D. Moore RHouseUtah-01 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Jan 19, 2024 5 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 17, 2024 2.4y ago | ![]() Jerry Moran RSenateKansas | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 14, 2023 34 days to disclose | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 17, 2024 2.4y ago | ![]() Jerry Moran RSenateKansas | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Dec 14, 2023 34 days to disclose | Flat·+0.0% +9.8% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 8, 2024 2.4y ago | ![]() Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Dec 12, 2023 27 days to disclose | Good buy·+$3.9K+48.5% +37.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2023 2.5y ago | ![]() Tommy Tuberville RSenateAlabama | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Health, Education, Labor, and Pensions | Oct 16, 2023 31 days to disclose | Missed gain·−$3.6K-44.4% +19.3% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 20, 2023 2.6y ago | ![]() Pete Ricketts RSenateNebraska | ↓sold | Johnson & Johnson JNJ | Sep 21, 2023 29 days to disclose | Missed gain·−$71.3K-40.7% +24.8% vs S&P 500 | $100K-$250K midpoint $175K |
Oct 13, 2023 2.6y ago | ![]() Kevin Hern RHouseOklahoma-01 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 19, 2023 24 days to disclose | Good buy·+$3.2K+40.3% −21.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 12, 2023 2.6y ago | ![]() Scott Franklin RHouseFlorida-18 | ↓sold | Johnson & Johnson JNJ | Sep 11, 2023 31 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 10, 2023 2.6y ago | ![]() Lois Frankel DHouseFlorida-22 | ↓sold | Johnson & Johnson JNJ | Sep 6, 2023 34 days to disclose | Flat·+0.0% +13.0% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 5, 2023 2.7y ago | ![]() Lloyd Doggett DHouseTexas-37 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Ways and Means | Sep 12, 2023 23 days to disclose | Good buy·+$3.3K+41.4% +29.6% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 4, 2023 2.7y ago | ![]() John R. Curtis RSenateUtah | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Sep 13, 2023 21 days to disclose | Good buy·+$3.3K+41.1% +29.2% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 3, 2023 2.7y ago | ![]() Sheldon Whitehouse DSenateRhode Island | ↔exchanged | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 24, 2023 40 days to disclose | price pending | $1K-$15K midpoint $8K |
Oct 3, 2023 2.7y ago | ![]() Sheldon Whitehouse DSenateRhode Island | ↔exchanged | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 24, 2023 40 days to disclose | price pending | $1K-$15K midpoint $8K |
Sep 22, 2023 2.7y ago | ![]() Dan Sullivan RSenateAlaska | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 22, 2023 31 days to disclose | Missed gain·−$3K-37.0% +25.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 18, 2023 2.7y ago | ![]() Dan Sullivan RSenateAlaska | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Commerce, Science, and Transportation | Aug 22, 2023 27 days to disclose | Missed gain·−$3K-37.0% +25.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 26, 2023 2.8y ago | ![]() Lois Frankel DHouseFlorida-22 | ↑bought | Johnson & Johnson JNJ | Aug 10, 2023 16 days to disclose | Good buy·+$2.7K+34.3% +24.2% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 23, 2023 2.8y ago | ![]() Michael Guest RHouseMississippi-03 | ↑bought | Johnson & Johnson JNJ | Aug 7, 2023 16 days to disclose | Good buy·+$2.7K+33.7% +22.8% vs S&P 500 | $1K-$15K midpoint $8K |